Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lübbert

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Leukemia Research|June 2, 2005
Combined targeting of the epigenetic silence in leukemia: cooperating activities of DNA methylation and histone deacetylation inhibitorsMichael Lübbert
Leukemia Research|December 17, 2009
Optimizing epigenetic therapy for myelodysplastic syndromes: issues and strategiesMichael Lübbert
Leukemia Research|December 17, 2009
Epigenetic therapy for myelodysplastic syndromes has entered center stageMichael Lübbert
Haematologica|June 14, 2006
Autologous hematopoietic stem cell transplantation for myelodysplastic syndromes: which cell source is preferable?Michael Lübbert
Cancer|October 5, 2006
Acute myeloid leukemia: epidemiology and etiologyBarbara Deschler, Michael Lübbert
Annals of Hematology|April 9, 2008
Current status of epigenetic treatment in myelodysplastic syndromesAndrea Kuendgen, Michael Lübbert
Oncogene|October 7, 2003
Epigenetic targets in hematopoietic malignanciesRainer Claus, Michael Lübbert
Critical Reviews in Oncology/Hematology|May 12, 2005
DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical resultsWerner Digel, Michael Lübbert
Cancer|October 23, 2014
Combining DNA methyltransferase and histone deacetylase inhibition to treat acute myeloid leukemia/myelodysplastic syndrome: achievements and challengesMichael Lübbert, Andrea Kuendgen
Seminars in Hematology|July 15, 2005
Decitabine in acute myeloid leukemiaMichael Lübbert, Mark Minden
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Leukemia Research|June 2, 2005
Combined targeting of the epigenetic silence in leukemia: cooperating activities of DNA methylation and histone deacetylation inhibitorsMichael Lübbert
Leukemia Research|December 17, 2009
Optimizing epigenetic therapy for myelodysplastic syndromes: issues and strategiesMichael Lübbert
Leukemia Research|December 17, 2009
Epigenetic therapy for myelodysplastic syndromes has entered center stageMichael Lübbert
Haematologica|June 14, 2006
Autologous hematopoietic stem cell transplantation for myelodysplastic syndromes: which cell source is preferable?Michael Lübbert
Cancer|October 5, 2006
Acute myeloid leukemia: epidemiology and etiologyBarbara Deschler, Michael Lübbert
Annals of Hematology|April 9, 2008
Current status of epigenetic treatment in myelodysplastic syndromesAndrea Kuendgen, Michael Lübbert
Oncogene|October 7, 2003
Epigenetic targets in hematopoietic malignanciesRainer Claus, Michael Lübbert
Critical Reviews in Oncology/Hematology|May 12, 2005
DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical resultsWerner Digel, Michael Lübbert
Cancer|October 23, 2014
Combining DNA methyltransferase and histone deacetylase inhibition to treat acute myeloid leukemia/myelodysplastic syndrome: achievements and challengesMichael Lübbert, Andrea Kuendgen
Seminars in Hematology|July 15, 2005
Decitabine in acute myeloid leukemiaMichael Lübbert, Mark Minden
Pageof 25